U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H19NO2
Molecular Weight 209.2848
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DOM

SMILES

COC1=CC(C)=C(OC)C=C1CC(C)N

InChI

InChIKey=NTJQREUGJKIARY-UHFFFAOYSA-N
InChI=1S/C12H19NO2/c1-8-5-12(15-4)10(6-9(2)13)7-11(8)14-3/h5,7,9H,6,13H2,1-4H3

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
1998 Jul
Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position: effects on 5-HT(2A/2C) receptor affinity.
2002 Aug 5
The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
2002 Dec
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats.
2002 May
Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex.
2003 Dec
Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
2003 Feb
Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
2003 Feb
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
2003 Jul
Low doses of non-NMDA glutamate receptor agonists alter neurobehavioural development in the rat.
2003 Jul-Aug
Functional study of rat 5-HT2A receptors using antisense oligonucleotides.
2003 Jun
Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
2003 May
Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.
2004 Apr 2
Stimulus effects of three sulfur-containing psychoactive agents.
2004 Aug
Common drugs of abuse--Part II.
2004 Spring
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
2005 Jan 5
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
2005 Jun
A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
2005 Mar 10
alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
2006 Oct
A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.
2007 Aug
Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity.
2007 Jul
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
2007 Jun
Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
2007 Sep 15
Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
2008 Aug
First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.
2008 Dec
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.
2008 Feb
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
2008 Nov
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
2009 Jul
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
2009 Mar
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices.
2009 Nov
Patents
Name Type Language
DOM
Common Name English
DL-4-METHYL-2,5-DIMETHOXYAMPHETAMINE
Systematic Name English
2,5-Dimethoxy-4-methylamphetamine [WHO-DD]
Common Name English
2,5-DIMETHOXY-4-METHYLPHENYLISOPROPYLAMINE
Systematic Name English
1-(2,5-DIMETHOXY-4-METHYLPHENYL)-2-AMINOPROPANE
Systematic Name English
(±)-2,5-DIMETHOXY-4-METHYLAMPHETAMINE
Systematic Name English
J401.288G
Code English
(±)-1-(4-METHYL-2,5-DIMETHOXYPHENYL)-2-AMINOPROPANE
Systematic Name English
DOM [MI]
Common Name English
2,5-DIMETHOXY-4-METHYLAMPHETAMINE
WHO-DD  
Systematic Name English
4-METHYL-2,5-DIMETHOXY-.ALPHA.-METHYLPHENETHYLAMINE
Systematic Name English
(±)-DOM
Common Name English
(RS)-DOM
Common Name English
4-METHYL-2,5-DIMETHOXYAMPHETAMINE
Systematic Name English
(±)-1-(2,5-DIMETHOXY-4-METHYLPHENYL)-2-AMINOPROPANE
Systematic Name English
DL-2,5-DIMETHOXY-4-METHYLAMPHETAMINE
Systematic Name English
2',5'-DIMETHOXY-4'-METHYLAMPHETAMINE
Common Name English
2,5-DIMETHOXY-.ALPHA.,4-DIMETHYLPHENYLETHYLAMINE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA PiHKAL
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
WIKIPEDIA Designer-drugs-2,5-Dimethoxy-4-methylamphetamine
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
DEA NO. 7395
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
Code System Code Type Description
HSDB
7595
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
EPA CompTox
DTXSID50860611
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
SMS_ID
100000144899
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
CAS
26011-50-7
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
SUPERSEDED
CAYMAN
11145
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
WIKIPEDIA
2,5-DIMETHOXY-4-METHYLAMPHETAMINE
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY 2,5-Dimethoxy-4-methylamphetamine (DOM; known on the street as STP, standing for "Serenity, Tranquility, and Peace") is a psychedelic and a substituted amphetamine. It was first synthesized by Alexander Shulgin, and later reported in his book PiHKAL: A Chemical Love Story. DOM is classified as a Schedule I substance in the United States, and is similarly controlled in other parts of the world. Internationally, it is a Schedule I drug under the Convention on Psychotropic Substances.[1] It is generally taken orally.
PUBCHEM
85875
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
FDA UNII
UKI9MLD5OI
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
EVMPD
SUB121767
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
CAS
15588-95-1
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
DRUG BANK
DB01528
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY
MERCK INDEX
m4731
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
PRIMARY Merck Index
CAS
18539-33-8
Created by admin on Sat Dec 16 05:12:00 GMT 2023 , Edited by admin on Sat Dec 16 05:12:00 GMT 2023
SUPERSEDED